Symbiotec Pharmalab Promoters Submit Revised Share Pledge Disclosures
Symbiotec Pharmalab Ltd 路 Encumbered Shares - Invocation / Release 路 16 Oct 2026, 10:52 pm
Symbiotec Pharmalab Promoters Submit Revised Share Pledge Disclosures Symbiotec Pharmalab submitted revised SEBI SAST disclosures on 16th Oct'26 correcting lender details for promoter share pledges re-created between 8th Sep'26 and 10th Sep'26 in favour of Nomura Capital (India) and Beacon Trusteeship. Pledges secure debenture issuances across promoter entities: Anil Satwani pledged 4,50,896 shares (0.70%), Sushil Satwani 3,13,938 shares (0.49%), Kashish Satwani 5,00,896 shares (0.78%), Satwani Holdings LLP 22,27,734 shares (3.47%), Kashish and Anil Satwani Family Trust 3,50,000 shares (0.54%), Arjun Anil Satwani Family Trust 21,99,104 shares (3.42%), and Krishna Anil Satwani Family Trust 21,99,104 shares (3.42%).
Original exchange filing (PDF)
More announcements from Symbiotec Pharmalab Ltd
- Intimation regarding change in Corporate Identification Number (CIN) and Listing Status of the Company. 路 17 Nov 2026
- Transcript of the Earnings conference call for the Analysts and Investors for the Quarter and Half year ended 路 12 Nov 2026
- Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time .... 路 12 Nov 2026
- Pursuant to Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording of Conference Call for Analysts and Investors held on November .... 路 06 Nov 2026
- Symbiotec Signs 10 Year take or Pay Agreement to Manufacture Fermentation based alternative protein for EU Innovator 路 06 Nov 2026
- The Monitoring Agency report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the utilisation and application of funds raised through the IPO of the Company .... 路 06 Nov 2026
- The Investor release being issued by the company, for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- Pursuant to regulations 30 of the SEBI Listing Regulations, Investor Presentation on the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026. 路 06 Nov 2026
